|
Volumn 294, Issue 7, 2005, Pages 842-844
|
Medical marijuana, American federalism, and the Supreme Court
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANNABIS;
DIAMORPHINE;
LYSERGIDE;
BRAIN TUMOR;
CLINICAL PROTOCOL;
COURT;
DOCTOR PATIENT RELATION;
DRUG APPROVAL;
DRUG CONTROL;
DRUG LEGISLATION;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE POLICY;
INOPERABLE CANCER;
LAW ENFORCEMENT;
MEDICAL PRACTICE;
NOTE;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
WASTING SYNDROME;
ARTICLE;
CANNABIS SMOKING;
GONZALES V. RAICH;
GOVERNMENT REGULATION;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
JURISPRUDENCE;
LEGAL APPROACH;
LEGAL ASPECT;
MEDICOLEGAL ASPECT;
PHYTOTHERAPY;
UNITED STATES;
GONZALES V. RAICH;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
CANNABIS;
DRUG AND NARCOTIC CONTROL;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH POLICY;
HUMANS;
LEGISLATION, MEDICAL;
MARIJUANA SMOKING;
PHYSICIAN-PATIENT RELATIONS;
PHYTOTHERAPY;
STATE GOVERNMENT;
SUPREME COURT DECISIONS;
UNITED STATES;
|
EID: 23844460022
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.294.7.842 Document Type: Note |
Times cited : (15)
|
References (23)
|